David E. Golan MD, PhD

David E. Golan, MD, PhD, became dean for basic science and graduate education at Harvard Medical School in 2014, after serving as dean for graduate education since 2008. He is a professor in the HMS Department of Biological Chemistry and Molecular Pharmacology, where his laboratory applies biophysical and cell-imaging methods to the study of membrane proteins in blood cells. He is also the HMS George R. Minot Professor of Medicine and senior physician in the Department of Medicine at Brigham and Women's Hospital and the Dana-Farber Cancer Institute, where he sees patients as a practicing hematologist and clinician-teacher.
br/> Golan founded the core course in pharmacology in the New Pathway curriculum at HMS and directed it from 1989 to 2006. He currently co-directs a translational pharmacology course in the Therapeutics Graduate Program, the Leder Human Biology and Translational Medicine Graduate Program, and the Master of Medical Sciences in Clinical Investigation at HMS. The curriculum is guided by the principle that drug mechanisms are best understood in the context of the physiological, biochemical and pathophysiological pathways on which the drugs act. By translating this principle into his course design, Golan has provided thousands of Harvard students with a foundation for lifelong learning in pharmacology and therapeutics.